Groups

The IDIGH program is comprised of fundamental research scientists and clinicians in four groups (please see details below the overview diagram), who jointly tackle infectious and immune-mediated diseases of global importance. Click research keywords  for a snapshot of our members’ research interest.
IDIGH Program OverviewCentre for Translational Biology (CTB) Members (Click here for the research focuses):

Currently, the IDIGH CTB group consists of 18 research laboratories, with a total of 123 full-time researchers and trainees.  All laboratories are located on E3 and E2 levels of the Research Institute of McGill University Health Centre (RI-MUHC), at the new state-of-the-art MUHC Glen campus that opened in the spring of 2015. Research conducted by IDIGH CTB laboratories is highly interdisciplinary and multidisciplinary and focused on five major themes of global health research (http://idigh.ca/research/). IDIGH CTB researchers have a strong track record of intra-IDIGH collaborations but also work with research groups outside IDIGH both nationally and internationally.  A major strength of research by IDIGH CTB groups is the close vicinity to the clinical facilities at the new MUHC Glen campus and the proximity to the health outcome/epidemiology component of IDIGH.  The synergistic interaction of basic biomedical, clinical and epidemiological research provides the framework for conducting work with high translational impact. 

Left panel: photo by Dr. M. Lee (Dr. D. Sheppard lab)

Left panel: photo by Dr. M. Lee (Dr. D. Sheppard lab)

Dr. Marcel Behr
Dr. Nicole Bernard
Dr. Inés Colmegna
Dr. John Di Battista
Dr. Momar Ndao
Dr. Martin Olivier
Dr. Ciro Piccirillo
Dr. Danuta Radzioch
Dr. Joyce Rauch
Dr. Michael Reed
Dr. Jean-Pierre Routy
Dr. Erwin Schurr
Dr. Don Sheppard
Dr. Christos Tsoukas
Dr. Bernard Turcotte
Dr. Donald Vinh
Dr. Chris Walpole
Dr. Brian Ward
Dr. Cédric Yansouni

Centre of Outcomes Research and Evaluation (CORE) Members:
Presently, the IDIGH Program has 16 CORE investigators.  The CORE members of our program carry out population and patient-oriented research, with focus on developing methodology, e.g. statical models to study various patient cohorts and global health problems. The CORE members will soon move to a building that is adjacent to the main MUHC campus. The close proximity of CORE members to CTB and Clinical Members of the IDIGH program does provide an important structural component for the generation of translational units that cover the spectrum of health care innovation.

Public TB hospital - photo by Dr. M. Pai

Public TB hospital – photo by Dr. M. Pai

Dr. Moshe Ben-Shoshan
Dr. Sasha Bernatsky
Dr. Paul Brassard
Dr. Marie-Josee Brouillette
Dr. Joseph Cox
Dr. Amrita Daftary
Dr. Alexandra De Pokomandy
Dr. Nandini Dendukuri
Dr. Theresa Gyorkos
Dr. Lawrence Joseph
Dr. Marina Klein
Dr. Bertrand Lebouché
Dr. Nitika Pai
Dr. Madhukar Pai
Dr. Jesse Papenburg
Dr. Caroline Quach
Dr. Giada Sébastiani
Dr. Évelyne Vinet

Clinical Members:
Currently, the IDIGH Clinical Research group consists of 26 investigators who conduct a broad range of clinical investigations, spanning Infectious Diseases, Clinical Immunology, Transplant and Gastroenterology.  Studies are conducted at a variety of sties of the MUHC, including the Glen campus, the MGH site and the Lachine campus.  A key focal point for clinical research is the newly developed Centre for Innovative Medicine that facilitates and streamlines outpatient clinical research in one state-of-the art facility.  Research conducted by IDIGH clinical investigators is highly collaborative on multiple levels, given the links with CTB researchers, CORE researchers and collaborators outside of the MUHC, both nationally and internationally.  A major strength of research by IDIGH investigators is the close vicinity of many clinical facilities to the CTB and the CORE, providing many opportunities for new research synergies. This interaction of research across the CIHR pillars positions IDIGH investigators for high-impact translational studies.

Dr. Waqqas AfifClinical group
Dr. Talat Bessissow
Dr. Alain Bitton
Dr. Martin Bitzan
Dr. Marcelo Cantarovich
Dr. Cecilia Costiniuk
Dr. Ruth Horn
Dr. Peter Lakatos
Dr. Richard Lalonde
Dr. Roger Leblanc
Dr. Pierre Lebel
Dr. Todd Lee
Dr. Michael Libman
Dr. Vivian Loo
Dr. Emily McDonald
Dr. Dorothy Moore

The new state-of-the-art MUHC, photo by Jing Liu

The new state-of-the-art MUHC, photo by Dr. Jing Liu

Dr. Emil Nashi
Dr. Francisco Noya
Dr. Christian Pineau
Dr. Earl Rubin
Dr. Makeda Semret
Dr. Ernest Seidman
Dr. Nancy Sheehan
Dr. Michael Starr
Dr. Jean Tchervenkov
Dr. David Thomson
Dr. Margaret Warner
Dr. Philip Wong

McGill University Campus-based Members:Bellini image
The IDIGH program presently has four McGill University campus-based researchers. Dr. Ken Dewar’s laboratory is located in the McGill University and Génome Québec Innovation Centre. His research focus is combining leading edge DNA sequencing technologies and bioinformatics to better understand genome structure and variation. Drs. Danielle Malo, Maya Saleh and Silvia Vidal are part of the McGill University’s Complex Traits Group, whose research focuses including employing mouse models and various genetic analysis tools to understand and elucidate pathogenesis and individual components of complex human diseases.
Dr. Ken Dewar
Dr. Danielle Malo
Dr. Maya Saleh
Dr. Silvia Vidal